Amanda Kasper

Title: Amanda Kasper: Innovator in Peptoid-Peptide Macrocycles

Introduction

Amanda Kasper is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceutical compositions through her innovative work on peptoid-peptide macrocycles. Her research focuses on developing compounds that may have therapeutic applications, particularly in relation to cancer and other diseases.

Latest Patents

Amanda holds a patent for "Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same." This patent describes the creation of peptoid-peptide macrocycles that exhibit inhibitory activity towards the Wnt signaling pathway. The Wnt signaling pathway is known to be associated with various diseases, including cancer and pulmonary fibrosis. The patent also outlines methods for synthesizing these macrocycles, as well as their potential applications in medical treatments.

Career Highlights

Amanda Kasper is affiliated with New York University, where she conducts her research and development work. Her innovative approach to drug design and her focus on the Wnt signaling pathway have positioned her as a key figure in her field. With her patent, she has contributed to the advancement of pharmaceutical sciences and the potential treatment of serious health conditions.

Collaborations

Amanda collaborates with esteemed colleagues, including Kent Kirshenbaum and Susan Logan. These partnerships enhance her research efforts and contribute to the development of new therapeutic strategies.

Conclusion

Amanda Kasper is a trailblazer in the field of pharmaceutical innovation, with her work on peptoid-peptide macrocycles paving the way for future advancements in medical treatments. Her contributions are vital in the ongoing fight against diseases associated with the Wnt signaling pathway.